Nuvation Bio Inc. (NUVB)
NYSE·Healthcare·Biotechnology
$5.75
-5.74%
Mkt Cap $2.12B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (18 analysts)
$16.00
Range $13.00 – $19.00
Implied Upside
+178.3%
Consensus $16.00 vs current $5.75
NYSE·Healthcare·Biotechnology
$5.75
-5.74%
Mkt Cap $2.12B
Buy
11
Hold
0
Sell
0
Price Target (18 analysts)
$16.00
Range $13.00 – $19.00
+178.3%
Consensus $16.00 vs current $5.75